Which regulatory change transformed pharmaceutical marketing in the US by allowing direct-to-consumer (DTC) advertising of prescription medications on television with full disclosure of risks?

The pharmaceutical industry spends billions annually on marketing strategies, but regulations and approaches have changed dramatically over time. This poll explores a key turning point in how prescription medications were marketed directly to consumers - a shift that fundamentally changed the relationship between patients, physicians, and pharmaceutical companies. Test your knowledge about this significant marketing evolution in the medical industry!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

The FDA's 1997 guidance that relaxed requirements for broadcast advertisements, allowing risk information to be provided through other means like websites or toll-free numbers
The Kefauver-Harris Amendment of 1962 that required drug manufacturers to prove efficacy and safety before marketing
The Prescription Drug Marketing Act of 1987 that established distribution channels for pharmaceuticals
The Medicare Modernization Act of 2003 that expanded insurance coverage for prescription medications